[go: up one dir, main page]

WO2007146359A3 - Sea lice antigen vaccines - Google Patents

Sea lice antigen vaccines Download PDF

Info

Publication number
WO2007146359A3
WO2007146359A3 PCT/US2007/013922 US2007013922W WO2007146359A3 WO 2007146359 A3 WO2007146359 A3 WO 2007146359A3 US 2007013922 W US2007013922 W US 2007013922W WO 2007146359 A3 WO2007146359 A3 WO 2007146359A3
Authority
WO
WIPO (PCT)
Prior art keywords
sea lice
antigen vaccines
antigen
promiscuous
immune responses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/013922
Other languages
French (fr)
Other versions
WO2007146359A2 (en
Inventor
Robert C Brown
Michael Kogut
Gordana Djordjevic
Toby Richardson
Abraham Anderson
Leslie Hickle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Enzymes LLC
Original Assignee
Diversa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38832528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2007146359(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Diversa Corp filed Critical Diversa Corp
Publication of WO2007146359A2 publication Critical patent/WO2007146359A2/en
Publication of WO2007146359A3 publication Critical patent/WO2007146359A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to compositions for inducing immune responses, including an antigen and a promiscuous T-cell epitope. Also provided are methods of inducing immune responses in hosts, comprising administering compositions comprising antigens and promiscuous T-cell epitopes to the host.
PCT/US2007/013922 2006-06-14 2007-06-13 Sea lice antigen vaccines Ceased WO2007146359A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US80469706P 2006-06-14 2006-06-14
US60/804,697 2006-06-14
US82024606P 2006-07-25 2006-07-25
US60/820,246 2006-07-25
US91107207P 2007-04-10 2007-04-10
US60/911,072 2007-04-10

Publications (2)

Publication Number Publication Date
WO2007146359A2 WO2007146359A2 (en) 2007-12-21
WO2007146359A3 true WO2007146359A3 (en) 2008-12-11

Family

ID=38832528

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/013922 Ceased WO2007146359A2 (en) 2006-06-14 2007-06-13 Sea lice antigen vaccines

Country Status (2)

Country Link
CL (1) CL2007001736A1 (en)
WO (1) WO2007146359A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6857875B2 (en) * 2015-05-19 2021-04-14 国立大学法人 熊本大学 New cell membrane penetrating peptide
NO345611B1 (en) * 2016-01-22 2021-05-10 Norifish As IgY antibody composition, and use of the composition for reduction of infestation and infection by a Caligidae
WO2019145730A1 (en) * 2018-01-25 2019-08-01 Benchmark Animal Health Limited Sea lice antigens and vaccines
CN111116727B (en) * 2020-01-14 2021-08-10 中国农业大学 Eimeria tenella rod-shaped body protein 41 and preparation method and application thereof
CN111514284A (en) * 2020-04-27 2020-08-11 中国农业大学 Chicken coccidiosis multivalent recombinant protein vaccine and preparation method and application thereof
CN111925449B (en) * 2020-08-21 2022-02-01 浙江鼎持生物制品有限公司 Recombinant CHO cell strain expressing chicken VP2 and chicken GAL-1 fusion protein and construction method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006010265A1 (en) * 2004-07-28 2006-02-02 National Research Council Of Canada Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006010265A1 (en) * 2004-07-28 2006-02-02 National Research Council Of Canada Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof

Also Published As

Publication number Publication date
WO2007146359A2 (en) 2007-12-21
CL2007001736A1 (en) 2008-03-24

Similar Documents

Publication Publication Date Title
WO2006041933A3 (en) Improved vaccines
WO2007092792A3 (en) Yeast-based vaccine for inducing an immune response
WO2007120673A3 (en) Immunogenic wt-1 peptides and methods of use thereof
WO2008021076A3 (en) Protein matrix vaccines and methods of making and administering such vaccines
WO2009039229A3 (en) Method of conferring a protective immune response to norovirus
WO2006113214A3 (en) Vaccine against pandemic strains of influenza viruses
MX352478B (en) Norovirus capsid and rotavirus vp6 protein for use as combined vaccine.
WO2007103048A3 (en) Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity
WO2008148057A3 (en) Cationic lipids compositions and methods for enhancing immune responses to vaccines
WO2006126981A3 (en) Compositions and methods for mucosal vaccination
WO2007130493A3 (en) Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
WO2011032161A3 (en) Vaccines directed to langerhans cells
WO2012116225A3 (en) Muc1 based glycolipopeptide vaccine with adjuvant
WO2016176624A3 (en) Porcine pestvirus, vaccines, and assays
CA2763359C (en) New human rotavirus strains and vaccines
WO2006081007A3 (en) Use of flagellin in tumor immunotherapy
WO2007024941A3 (en) Polyvalent vaccine
WO2011156751A3 (en) Immunogenic vaccine
WO2011106607A3 (en) Subunit vaccines for herpes viruses and methods of use
WO2009135199A3 (en) Vaccine compositions and methods
WO2007144647A3 (en) Adjuvant compositions
WO2006133879A3 (en) Vaccines for immunization against helicobacter
WO2007146359A3 (en) Sea lice antigen vaccines
WO2010148496A8 (en) Lipidated tumor- associated antigens and immunotherapeutic compositions
WO2006071983A3 (en) Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07809539

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07809539

Country of ref document: EP

Kind code of ref document: A2